J&J kicked off the new year with a bang, shelling out more than $78 million to air eight TV ads for Tremfya throughout ...

Janssen Biotech’s TV advertisement for Tremfya misbrands the drug, “and makes the distribution of the drug in violation of the Federal Food, Drug, and Cosmetic Act,” according to a letter from the FDA ...

Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...

Tremfya’s reign atop the TV pharma ad rankings continued for yet another month as the Johnson & Johnson brand topped iSpot.tv’s list for October. Tremyfa achieved an impressions share of voice (SOV) ...

While the debate over pharmaceutical advertising heats up in Washington, one major pharma group is ramping up its presence on US radio. Media Monitors’ Spot Ten Radio rankings also show a familiar ...